Member Info for Chelsea11

Not forgetting of course that the financial firepower EKF are sitting on, may result in another earnings enhancing acquisition and possibly not that far into the future either.

Yep, the trees are whistling for the dogs today C7!

KTBFFH

New flagship product launch, unprecedented level of orders on the books, huge cash pile for M&A.

What’s not to like?

Berm.

For the record, no egg sucking here. I’ve been here 2 years now and it’s these kind of transparent, informative posts that have helped me to build knowledge of the company and science. Thank you and to others, for providing them.

Good luck next week everyone. Some red hot news to go with the extreme heat would be very cool :-)

When you look at some of the carp allowed on Wikipedia eg. List of people who died on the toilet, it doesn’t make a lot of sense to me to deny Burble’s work.

The real reason why should really be flushed out.

I can’t see the drone delivery system taking off.

Let’s not forget SCIB1 also. Quite where it fits into the batting order below I don’t know (and don’t fancy going down Ray’s wormhole :-)).

From the RNS 15/06:

“Professor Lindy Durrant, Chief Executive Officer, Scancell, commented: "The approved amendments will expand the patient population eligible to receive SCIB1 and are therefore expected to increase recruitment rates, allowing the study to remain on track to deliver initial efficacy data in 2022. We believe that SCIB1 administration in combination with doublet therapy has the potential to offer greater efficacy than checkpoint inhibitors alone, without increasing toxicity."

Thanks SB. I’m hopeful for an RNS Trading Update soon and for the positive messaging and progress to date to be included within. I think that’s needed here to reverse the drop.

Hi Chester.

Completely get what you’re saying. I’m just pointing out that Nottingham shows as “Recruiting” on clinicaltrials.gov and the last updated date there, shows as May 18th.

Cheers.

I think Nottingham was already there as shows as Recruiting on clinicaltrials.gov and that was last updated May 18th.

Unless they have updated but not updated the updated date :-)

From 11/04 RNS……….

Leading oncology clinical research sites and investigators across the UK have agreed to contribute patients to the ModiFY study. The first wave of clinical sites is now open for recruitment and in due course the Company expects up to 20 sites to be open and recruiting patients.

Crackin also said “sub 5p” rather than the 6p of just a couple of weeks back.

https://www.youtube.com/watch?v=h4-lKMGII_k

That would be amazing Burble.

https://www.itv.com/news/granada/2022-07-04/woman-given-months-to-live-told-she-is-cancer-free

The Christie is a Modi-1 Trial location I believe (not yet recruiting according to clinicaltrials website).

I’ve pinged the journalist more than once, just to point him to RNS as they’ve landed. Not received any response but didn’t expect one. It would not surprise me at all if Sky are following progress without my signposts.

Agree Ray. My point was that I don’t think anyone on here could say it won’t / can’t ever happen at some future point in time.

Hey Cleaner. I also believe the VHS / Betamax example was short-sighted in the context of Scancell.

Biopharma companies collaborate very frequently to harness different technologies and expertise. It’s not hard to find multiple examples to evidence that.

Ruck - you made a wildly inaccurate and offensive statement to both shareholders and Scancell. You are now trying your best (and failing miserably in front of the whole BB) to weasel you way out of it. Simple as that.

PS: As you are clearly a Last Word Merchant, please respond and then we can close the convo.

Ruck - “ New investors are far more likely to be attracted by open discussion and a positive conclusion.”

I’m sure many new investors were attracted by being told they would be kept in the dark and fed ****.

Incredible.

Far more considered than insulting shareholders by telling them they are being kept in the dark and being fed ****!